Back to Research Peptides

Metabolic/GLP-1
Retatrutide 20MG
Triple GIP/GLP-1/glucagon receptor agonist Retatrutide, 20 mg lyophilised vial.
£85.00
In stock
About this product
Retatrutide is an investigational triple agonist at the GIP, GLP-1 and glucagon receptors of broad interest in metabolic research. 30 mg lyophilised vial. Research use only.
